Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nicotine Sublingual Tablets vs Nicorette Lozenge
NCT02906995Phase 1Completed
- Sponsor
- Friends Research Institute
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (2 arms), sponsored by Friends Research Institute. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration, Area Under the Curve from time 0 to infinity and 2 more. Started May 2017; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02906995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906995.